Package 52427-274-30

{"route": ["ORAL"], "spl_id": "cc98185d-7e2e-eea6-8bbd-08585361b654", "openfda": {"upc": ["0352427272011", "0352427274305", "0352427273759"], "unii": ["9TN87S3A3C"], "rxcui": ["1116320", "1116331", "1116339", "1116341", "1116349", "1116351"], "spl_set_id": ["e633ff0b-eab7-f167-8d08-e9236e54042b"], "manufacturer_name": ["Almatica Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-274-30)", "package_ndc": "52427-274-30", "marketing_end_date": "20260401", "marketing_start_date": "20140117"}], "brand_name": "Naprelan", "product_id": "52427-274_cc98185d-7e2e-eea6-8bbd-08585361b654", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "52427-274", "generic_name": "Naproxen Sodium", "labeler_name": "Almatica Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naprelan", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "750 mg/1"}], "application_number": "NDA020353", "marketing_category": "NDA", "marketing_end_date": "20260401", "marketing_start_date": "20140117"}